Sergiy Nadtochiy
Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Myocardial Reperfusion Injury | 10 | 2006 | 29 |
Why?
|
Ischemic Preconditioning, Myocardial | 8 | 2006 | 9 |
Why?
|
Mitochondria, Heart | 8 | 2006 | 20 |
Why?
|
Sirtuin 1 | 2 | 2010 | 7 |
Why?
|
Cardiotonic Agents | 3 | 2007 | 21 |
Why?
|
Tiopronin | 2 | 2007 | 5 |
Why?
|
Lysine | 2 | 2010 | 47 |
Why?
|
Myocardium | 5 | 2006 | 119 |
Why?
|
Alkenes | 2 | 2008 | 6 |
Why?
|
Heart | 3 | 2009 | 88 |
Why?
|
Mitochondrial Proteins | 4 | 2008 | 26 |
Why?
|
Rats, Sprague-Dawley | 9 | 2006 | 257 |
Why?
|
Mitochondrial Membrane Transport Proteins | 1 | 2008 | 14 |
Why?
|
S-Nitrosothiols | 5 | 2006 | 5 |
Why?
|
Purines | 1 | 2008 | 23 |
Why?
|
Protons | 1 | 2006 | 30 |
Why?
|
Rats | 11 | 2006 | 530 |
Why?
|
Animals | 15 | 2006 | 1031 |
Why?
|
Disease Models, Animal | 4 | 2008 | 349 |
Why?
|
Electron Transport Complex I | 4 | 2006 | 8 |
Why?
|
Acetylation | 2 | 2010 | 46 |
Why?
|
NAD | 2 | 2010 | 41 |
Why?
|
Mice, Inbred C57BL | 5 | 2009 | 318 |
Why?
|
Reperfusion Injury | 2 | 2009 | 22 |
Why?
|
Myocytes, Cardiac | 2 | 2010 | 40 |
Why?
|
Nitro Compounds | 2 | 2008 | 9 |
Why?
|
Male | 13 | 2006 | 1553 |
Why?
|
Sulfhydryl Compounds | 2 | 2009 | 42 |
Why?
|
Mice | 7 | 2009 | 623 |
Why?
|
Mitochondria | 4 | 2006 | 100 |
Why?
|
Gastric Bypass | 2 | 2007 | 10 |
Why?
|
Mice, Knockout | 2 | 2009 | 265 |
Why?
|
Reactive Oxygen Species | 2 | 2007 | 112 |
Why?
|
Membrane Potentials | 2 | 2006 | 99 |
Why?
|
Nitrosation | 3 | 2006 | 6 |
Why?
|
Nitric Oxide | 3 | 2008 | 85 |
Why?
|
Blotting, Western | 2 | 2009 | 275 |
Why?
|
Animals, Genetically Modified | 1 | 2011 | 29 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2011 | 6 |
Why?
|
Renin-Angiotensin System | 1 | 2011 | 15 |
Why?
|
Mass Spectrometry | 2 | 2008 | 57 |
Why?
|
Superoxide Dismutase | 1 | 2011 | 46 |
Why?
|
Forkhead Transcription Factors | 1 | 2011 | 44 |
Why?
|
Reactive Nitrogen Species | 1 | 2010 | 9 |
Why?
|
Cytosol | 1 | 2011 | 79 |
Why?
|
Myocardial Ischemia | 2 | 2008 | 62 |
Why?
|
Sesquiterpenes | 1 | 2009 | 24 |
Why?
|
Linoleic Acids | 1 | 2008 | 7 |
Why?
|
Potassium Channels | 1 | 2010 | 33 |
Why?
|
Mitochondrial ADP, ATP Translocases | 1 | 2008 | 4 |
Why?
|
Fatty Acids | 1 | 2009 | 48 |
Why?
|
Endocannabinoids | 1 | 2008 | 2 |
Why?
|
Cyclic GMP | 1 | 2008 | 30 |
Why?
|
Chromatography, Liquid | 1 | 2008 | 33 |
Why?
|
Obesity, Morbid | 1 | 2008 | 28 |
Why?
|
Weight Loss | 1 | 2008 | 51 |
Why?
|
Ion Channels | 1 | 2008 | 61 |
Why?
|
Myocardial Infarction | 2 | 2009 | 129 |
Why?
|
Cell Membrane | 1 | 2009 | 170 |
Why?
|
Guanosine Diphosphate | 1 | 2006 | 9 |
Why?
|
Mitochondrial Membranes | 1 | 2006 | 12 |
Why?
|
Body Weight | 1 | 2007 | 178 |
Why?
|
Nitrates | 1 | 2006 | 27 |
Why?
|
Cell Membrane Permeability | 1 | 2006 | 57 |
Why?
|
Oxidation-Reduction | 3 | 2009 | 124 |
Why?
|
Oxygen | 1 | 2006 | 179 |
Why?
|
Signal Transduction | 1 | 2011 | 313 |
Why?
|
Carrier Proteins | 1 | 2006 | 177 |
Why?
|
Membrane Proteins | 1 | 2006 | 233 |
Why?
|
Superoxides | 2 | 2010 | 36 |
Why?
|
Calcium | 1 | 2007 | 208 |
Why?
|
Membrane Potential, Mitochondrial | 2 | 2009 | 18 |
Why?
|
Antioxidants | 2 | 2009 | 84 |
Why?
|
Energy Metabolism | 2 | 2007 | 80 |
Why?
|
Sensitivity and Specificity | 2 | 2006 | 427 |
Why?
|
Gene Expression Regulation | 2 | 2007 | 277 |
Why?
|
Muscle, Skeletal | 2 | 2007 | 114 |
Why?
|
Fumarates | 1 | 2011 | 15 |
Why?
|
Renin | 1 | 2011 | 26 |
Why?
|
Amides | 1 | 2011 | 28 |
Why?
|
Osmotic Pressure | 1 | 2010 | 16 |
Why?
|
NADP | 1 | 2010 | 17 |
Why?
|
Nitrogen Oxides | 1 | 2010 | 11 |
Why?
|
Peroxides | 1 | 2010 | 12 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2010 | 42 |
Why?
|
Arginine | 1 | 2010 | 57 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2009 | 27 |
Why?
|
Proteomics | 1 | 2010 | 36 |
Why?
|
Thioredoxins | 1 | 2009 | 16 |
Why?
|
Extracellular Space | 1 | 2009 | 58 |
Why?
|
Mercaptoethanol | 1 | 2009 | 9 |
Why?
|
Myoblasts | 1 | 2009 | 17 |
Why?
|
Tandem Mass Spectrometry | 1 | 2009 | 17 |
Why?
|
Electron Transport Complex III | 1 | 2009 | 6 |
Why?
|
Biochemistry | 1 | 2009 | 15 |
Why?
|
Electron Transport Complex II | 1 | 2009 | 4 |
Why?
|
Cell Death | 1 | 2009 | 94 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 48 |
Why?
|
Electron Transport Complex IV | 1 | 2009 | 22 |
Why?
|
Aorta, Thoracic | 1 | 2009 | 54 |
Why?
|
Glycolysis | 1 | 2009 | 23 |
Why?
|
Vasodilation | 1 | 2009 | 30 |
Why?
|
Dimerization | 1 | 2009 | 92 |
Why?
|
Mice, Transgenic | 1 | 2011 | 209 |
Why?
|
Oxidoreductases | 1 | 2009 | 41 |
Why?
|
HeLa Cells | 1 | 2009 | 107 |
Why?
|
Oxygen Consumption | 1 | 2009 | 86 |
Why?
|
Lymphoma | 1 | 2009 | 96 |
Why?
|
Digestion | 1 | 2007 | 3 |
Why?
|
Xylose | 1 | 2007 | 8 |
Why?
|
Glutathione | 1 | 2009 | 65 |
Why?
|
Cell Survival | 1 | 2009 | 229 |
Why?
|
Feeding Behavior | 1 | 2007 | 29 |
Why?
|
Enzyme Activation | 1 | 2009 | 177 |
Why?
|
Feces | 1 | 2007 | 43 |
Why?
|
Vagus Nerve | 1 | 2007 | 25 |
Why?
|
Energy Intake | 1 | 2007 | 38 |
Why?
|
Body Composition | 1 | 2007 | 44 |
Why?
|
Hypothalamus | 1 | 2007 | 33 |
Why?
|
Cell Line, Tumor | 1 | 2009 | 208 |
Why?
|
Stomach | 1 | 2007 | 44 |
Why?
|
Flow Cytometry | 1 | 2009 | 216 |
Why?
|
NF-kappa B | 1 | 2009 | 114 |
Why?
|
Oxidative Stress | 1 | 2009 | 119 |
Why?
|
Cell Line | 1 | 2009 | 375 |
Why?
|
Cells, Cultured | 1 | 2010 | 447 |
Why?
|
RNA, Messenger | 1 | 2011 | 394 |
Why?
|
Models, Biological | 1 | 2009 | 410 |
Why?
|
Time Factors | 1 | 2007 | 896 |
Why?
|
Humans | 2 | 2009 | 1856 |
Why?
|
